Session Details

[28-54-am]Clinical Pharmacy 14, Pharmacotherapies (Clinical/Community health care/TDM)

Sat. Mar 28, 2026 9:30 AM - 11:30 AM JST
Sat. Mar 28, 2026 12:30 AM - 2:30 AM UTC
Room 54 (C201, Bldg. 2, Area 2 [2F]) (2)
Discusser: Hisao Kano, Hideto To

[28-54-am-09]The cancer-suppressing effect of SGLT2 inhibitors in non-diabetic heart failure patients

○yukako hatanaka1, koko nakanishi1, yasushi habu1, aya ino1, yoshimi tomita1, hiroaki hamano2, Mitsuhiro Goda3, Yoshito Zamami2, Sachiko Tanaka1 (1. Kobe Pharm. Univ., 2. Okayama Uni.Hosp.Pharm., 3. Grad. Sch. Biomed. Health Sci., Hiroshima Univ.)

[28-54-am-10]Analysis of dehydration associated with concomitant use of SGLT2 inhibitors and AQP2-related drugs using FAERS database

○Rina Matsuoka1,2, Shinsuke Akagi1, Hideki Mori2, Yuichi Tasaka1 (1. Grad. Sch. Pharm., Shujitsu Univ. Dept. Pharm., 2. Okayama Red Cross Hosp.)

[28-54-am-11S]Trends in pharmacotherapy for patients with chronic heart failure: changes following the guideline revision

○Koko Nakanishi1, Yuta Kamimura1, Rei Ishizaka1, Aya Ino1, Yasushi Habu1, Sachiko Tanaka1, Yukako Hatanaka1 (1. Kobe Parmaceutical University)

[28-54-am-12S]Changes in Plasma Concentrations of Clozapine and Its Metabolites and Their Association with Drug Metabolism-Related Factors in Patients with Schizophrenia

○Kengo Fujii1, Honami Yokoe2, Chiaki Takada1, Yuka Nagatsuka1, Masahiko Yamada2, Nozomi Fukuda2, Yusuke Shimomura2, Chiyomi Shiode2, Yasutaka Fujita2, Yu Nakamura2, Yuhki Sato1 (1. Fac. Pharm. Pharmaceut. Sci., Fukuyama Univ, 2. Kokoro Hospital Kusatsu)

[28-54-am-13S]Association of Immune Checkpoint Inhibitoron peripheral neuropathy in Taxane-based patients: evidence from JADER and FAERS Analysis

○Ai Kitaoka1, Tomoyosi Miyamoto1, Rio Sugimoto1, Ayano Seo1, Satoko Katsuragi1 (1. School of Pharmacy, Hyogo Medical University)

[28-54-am-15S]Questionnaire Survey on Hospital Pharmacist intervention and Collaboration in Home Medical Care

○Sayaka Nakagawa1, Hiroki Sugiyama1,3, Kotone Miyazaki1, Minoru Oshinoya2, Kiyoshi Sasayama2, Kousuke Okamoto1, Hiroaki Yamaguchi3, Kazuhiro Ishikawa1 (1. Faculty of Pharm. Sci., Hokuriku Univ., 2. Dept. Pharm., Asanogawa General Hospital, 3. Dept. Pharm., Yamagata Univ. Hosp.)

[28-54-am-16S]Population pharmacokinetics of riociguat in chronic thromboembolic pulmonary hypertension patients

○Hiroto Watanabe1, Motoyasu Miura1, Mariko Tatsuguchi2, Yuma Nishiyama1, Sayuri Kawamoto1, Ryota Sato2, Keitaro Akita2, Yuichiro Maekawa2, Naoki Inui2, Shinya Uchida1 (1. Sch. Pharm. Sci., Univ. Shizuoka, 2. Hamamatsu Univ. Sch. Med.)